Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med. 2011 Jun 01; 3(85):85ra46.
View in:
PubMed
subject areas
Adolescent
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20
Apoptosis
Blotting, Western
Cells, Cultured
Child
Female
Fluorescent Antibody Technique
Glomerulosclerosis, Focal Segmental
Humans
Immunologic Factors
Immunoprecipitation
Male
Podocytes
Polymerase Chain Reaction
Retrospective Studies
Rituximab
Sphingomyelin Phosphodiesterase